While so far only selected ABC transporters, including ABCB1 and ABCG2, have been studied for their role in BCL-2 inhibitor transport66,67, we investigated all 48 ABC transporters using an unbiased CRISPR/Cas9 screening approach in AML. This evidence concerns the gene BCL2 and acute myeloid leukemia.